Jaguar Health, Inc. (NASDAQ:JAGX – Get Free Report) saw a significant drop in short interest in June. As of June 30th, there was short interest totalling 313,000 shares, a drop of 11.4% from the June 15th total of 353,400 shares. Based on an average daily trading volume, of 1,060,000 shares, the short-interest ratio is presently 0.3 days. Currently, 7.5% of the company’s stock are short sold.
Jaguar Health Trading Down 2.2 %
JAGX traded down $0.09 on Wednesday, hitting $4.08. The company had a trading volume of 305,636 shares, compared to its average volume of 830,612. The company has a quick ratio of 1.39, a current ratio of 1.89 and a debt-to-equity ratio of 1.84. The company’s fifty day moving average price is $6.29 and its 200 day moving average price is $6.62. Jaguar Health has a 1-year low of $3.07 and a 1-year high of $41.76.
Jaguar Health (NASDAQ:JAGX – Get Free Report) last issued its quarterly earnings data on Tuesday, May 14th. The biotechnology company reported ($3.60) earnings per share for the quarter. The firm had revenue of $2.35 million during the quarter. Jaguar Health had a negative return on equity of 642.15% and a negative net margin of 377.95%. Equities analysts anticipate that Jaguar Health will post -5.42 earnings per share for the current year.
Analyst Ratings Changes
View Our Latest Report on Jaguar Health
Jaguar Health Company Profile
Jaguar Health, Inc, a commercial stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress, specifically chronic and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products.
See Also
- Five stocks we like better than Jaguar Health
- How Technical Indicators Can Help You Find Oversold StocksĀ
- Real Estate Stock Signals a Boom in Manufacturing Activity
- What is the Dogs of the Dow Strategy? Overview and Examples
- This Medical Giant’s Stock Rebounds: A 15% Upside Is the Minimum
- What to Know About Investing in Penny Stocks
- Financial Giant’s Shares Soar on EPS Beat and Record Asset Levels
Receive News & Ratings for Jaguar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jaguar Health and related companies with MarketBeat.com's FREE daily email newsletter.